Updates to the GGC Infection Management Guideline (IMG) and IVOST guideline reflect a review of evidence including:
- increasing resistance in Gram negative organisms to co-amoxiclav and temocillin
- the support of oral (over intravenous) therapy and shorter course (5 day) treatment particularly in lower respiratory tract infections
- promotion of patient centered care by informing the patient and recording on the Kardex the indication and planned duration of treatment